TGFB1 and glioblastoma: Glioblastoma cells can downregulate the expression of the activating NK cell receptor NKG2D through a TGFβ-dependent pathway, confirming the significant role of TGFβ as a key molecular mechanism for inhibiting the immune response by glial cells (98, 99).